From: The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET
All women
TAX → FEC
FEC → TAX
P valuea
≥ 75% reduction in SUVmax
28/57 (49.1)
17/28 (60.7)
11/28 (39.3)
0.63
Node-negative
18/28 (64.2)
8/18 (44.4)
10/18 (55.5)
0.9
Node-positive
10/28 (35.7)
9/10 (90.0)
1/10 (10.0)
0.001